In prostate cancer and glioblastoma, a fraction of angiogenesis involves immature vessels with the absence of associated pericytes or smooth muscle cells that express α-SMA, which are selectively obliterated by VEGF withdrawal [45]. Here, VEGFA is linked to prostate cancer.